RCUS
Price
$24.59
Change
-$1.56 (-5.97%)
Updated
Sep 11 closing price
Capitalization
3.13B
59 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$10.62
Change
+$0.04 (+0.38%)
Updated
Sep 11 closing price
Capitalization
1.8B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RCUS vs VIR

RCUS vs VIR Comparison Chart in %
View a ticker or compare two or three
VS
RCUS vs. VIR commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a Hold and VIR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($3.13B) has a higher market cap than VIR($1.8B). VIR YTD gains are higher at: 76.119 vs. RCUS (3.189). VIR has higher annual earnings (EBITDA): -268.68M vs. RCUS (-439M). RCUS has more cash in the bank: 702M vs. VIR (533M). VIR has less debt than RCUS: VIR (93.3M) vs RCUS (114M). VIR has higher revenues than RCUS: VIR (303M) vs RCUS (117M).
RCUSVIRRCUS / VIR
Capitalization3.13B1.8B174%
EBITDA-439M-268.68M163%
Gain YTD3.18976.1194%
P/E RatioN/AN/A-
Revenue117M303M39%
Total Cash702M533M132%
Total Debt114M93.3M122%
FUNDAMENTALS RATINGS
RCUS vs VIR: Fundamental Ratings
RCUS
VIR
OUTLOOK RATING
1..100
7088
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
3937
P/E GROWTH RATING
1..100
9823
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VIR's Valuation (57) in the null industry is in the same range as RCUS (73) in the Pharmaceuticals Major industry. This means that VIR’s stock grew similarly to RCUS’s over the last 12 months.

VIR's Profit vs Risk Rating (100) in the null industry is in the same range as RCUS (100) in the Pharmaceuticals Major industry. This means that VIR’s stock grew similarly to RCUS’s over the last 12 months.

VIR's SMR Rating (96) in the null industry is in the same range as RCUS (98) in the Pharmaceuticals Major industry. This means that VIR’s stock grew similarly to RCUS’s over the last 12 months.

VIR's Price Growth Rating (37) in the null industry is in the same range as RCUS (39) in the Pharmaceuticals Major industry. This means that VIR’s stock grew similarly to RCUS’s over the last 12 months.

VIR's P/E Growth Rating (23) in the null industry is significantly better than the same rating for RCUS (98) in the Pharmaceuticals Major industry. This means that VIR’s stock grew significantly faster than RCUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCUSVIR
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (RCUS: $24.59 vs. VIR: $10.62)
Brand notoriety: RCUS and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 345% vs. VIR: 96%
Market capitalization -- RCUS: $3.13B vs. VIR: $1.8B
RCUS [@Biotechnology] is valued at $3.13B. VIR’s [@Biotechnology] market capitalization is $1.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green while VIR’s FA Score has 1 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • RCUS’s TA Score: 5 bullish, 5 bearish.
  • VIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both RCUS and VIR are a good buy in the short-term.

Price Growth

RCUS (@Biotechnology) experienced а -17.09% price change this week, while VIR (@Biotechnology) price change was -6.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

RCUS is expected to report earnings on Nov 10, 2026.

VIR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
RCUS
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DSMC43.700.55
+1.27%
Distillate Small/Mid Cash Flow ETF
STEN28.350.25
+0.89%
iShares Large Cap 10% Trgt Buffr Sep ETF
EFAX54.970.41
+0.75%
State Street®SPDR®MSCIEAFEFsslFlRsvFrETF
SHM47.310.01
+0.02%
Stt Strt® SPDR® Nuveen ICE S/T MuncplETF
OPPG38.18N/A
N/A
WisdomTree GeoAlpha Opportunities Fund

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+0.38%
BEAM - VIR
54%
Loosely correlated
-1.56%
DNLI - VIR
52%
Loosely correlated
-1.45%
EDIT - VIR
51%
Loosely correlated
+1.89%
RCUS - VIR
50%
Loosely correlated
-5.97%
CRBU - VIR
49%
Loosely correlated
-7.30%
More